Gheorghe Doros, PhD

Associate Professor, Biostatistics
Gheorghe Doros
Crosstown Center – CT331
View full profile at BUMC


Gheorghe Doros is Associate Professor of Biostatistics and director of the Biostatistics Consulting Group. He received his PhD in statistics from Yale University and joined BUSPH’s Department of Biostatistics in 2006 after spending two years at Eli Lilly, as a member of that company's Drug Discovery and Toxicology department. Professor Doros’s interests focus on Clinical Trials, Bayesian Statistics, asymptotic statistics, testing, and computational statistics. He is involved in projects that evaluate the effects of physical and emotional stresses of caregiving on physical and psychological health. He also serves as a statistical consultant to Boston Medical Center’s Amyloid Center and as biostatistician for the Boston University Clinical Research Training (CREST) project. At BUSPH, he teaches the course in Computational Statistics and Generalized Linear Models.

Other Positions

  • Boston Medical Center


  • Yale University, PhD
  • Yale University, MA
  • University of Bucharest, MS
  • University of Bucharest, BS

Classes Taught

  • SPHBS853
  • SPHBS853
  • SPHBS980
  • SPHBS980
  • SPHBS980


  • Published on 12/13/2016

    Siracuse JJ, Krafcik BM, Farber A, Kalish JA, McChesney A, Rybin D, Doros G, Eslami MH. Contemporary open repair of ruptured abdominal aortic aneurysms. J Vasc Surg. 2016 Dec 13. PMID: 27986483.

    Read at: PubMed
  • Published on 11/16/2016

    Krisciunas GP, Castellano K, McCulloch TM, Lazarus CL, Pauloski BR, Meyer TK, Graner D, Van Daele DJ, Silbergleit AK, Crujido LR, Rybin D, Doros G, Kotz T, Langmore SE. Impact of Compliance on Dysphagia Rehabilitation in Head and Neck Cancer Patients: Results from a Multi-center Clinical Trial. Dysphagia. 2016 Nov 16. PMID: 27848021.

    Read at: PubMed
  • Published on 10/5/2016

    Eslami MH, Rybin DV, Doros G, Farber A. Description of a risk predictive model of 30-day postoperative mortality after elective abdominal aortic aneurysm repair. J Vasc Surg. 2017 Jan; 65(1):65-74.e2. PMID: 27720320.

    Read at: PubMed
  • Published on 8/30/2016

    Vaduganathan M, Bhatt DL, Cryer BL, Liu Y, Hsieh WH, Doros G, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Cannon CP. Reply: High Risk of Gastrointestinal Bleeding on Dual Antiplatelet Treatment. J Am Coll Cardiol. 2016 Aug 30; 68(9):981-2. PMID: 27561775.

    Read at: PubMed
  • Published on 7/21/2016

    Inagaki E, Farber A, Eslami MH, Kalish J, Peacock MR, Rybin DV, Doros G, Siracuse JJ. Preoperative Hypoalbuminemia Is Associated With Poor Clinical Outcomes After Open and Endovascular Abdominal Aortic Aneurysm Repair. J Vasc Surg. 2016 Aug; 64(2):547. PMID: 27763303.

    Read at: PubMed
  • Published on 7/13/2016

    Doros G, Lavin PT, Daley M, Miller LE. A method for establishing class III medical device equivalence: sodium hyaluronate (GenVisc 850) for the treatment of knee osteoarthritis. Med Devices (Auckl). 2016; 9:205-11. PMID: 27471412.

    Read at: PubMed
  • Published on 7/1/2016

    Moreira CC, Leung AD, Farber A, Rybin D, Doros G, Siracuse JJ, Kalish J, Eslami MH. Alternative conduit for infrageniculate bypass in patients with critical limb ischemia. J Vasc Surg. 2016 Jul; 64(1):131-139.e1. PMID: 27345506.

    Read at: PubMed
  • Published on 6/27/2016

    Gale HI, Bobbitt CA, Setty BN, Sprinz PG, Doros G, Williams DD, Morrison TC, Kalajian TA, Tu P, Mundluru SN, Castro-Aragon I. Expected Sonographic Appearance of the Spleen in Children and Young Adults With Sickle Cell Disease: An Update. J Ultrasound Med. 2016 Aug; 35(8):1735-45. PMID: 27353067.

    Read at: PubMed
  • Published on 6/22/2016

    Krafcik BM, Farber A, Eslami MH, Kalish JA, Rybin D, Doros G, King EG, Siracuse JJ. The Role of the Model of End-Stage Liver Disease Score in Predicting Outcomes of Carotid Endarterectomy. Vasc Endovascular Surg. 2016 Aug; 50(6):380-4. PMID: 27334479.

    Read at: PubMed
  • Published on 6/14/2016

    Yassin A, Almehmadi Y, Saad F, Doros G, Gooren L. The Author's Reply: Changing testosterone had no direct effect on HbA1c or weight in diabetic men when TRT was interrupted and then resumed. Clin Endocrinol (Oxf). 2016 Sep; 85(3):500-1. PMID: 27222377.

    Read at: PubMed

View 130 more publications:View full profile at BUMC

News & In the Media